Abercrombie & Fitch Co. vs Axogen Inc — how do they compare? Abercrombie & Fitch Co. trades at $115.48 (market cap $5.24B), while Axogen Inc trades at $48.21 (market cap $2.61B). The key difference: Abercrombie & Fitch Co. is far larger — about 2× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Abercrombie & Fitch Co. nearer its low. Which is the better fit depends on your goals.
| ANF | AXGN | |
|---|---|---|
Market Cap | $5.24B | $2.61B |
Sector | Consumer Cyclical | Technology |
52-Week High | $129.85 | $48.48 |
52-Week Low | $65.61 | $14.16 |
Enterprise Value | $5.91B | $2.52B |
Trailing returns across standard periods
Latest headlines on both assets
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumer through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Read more on ANF →Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →